BEOVU Trademark
Trademark Overview
On Monday, November 6, 2017, a trademark application was filed for BEOVU with the United States Patent and Trademark Office. The USPTO has given the BEOVU trademark a serial number of 79226907. The federal status of this trademark filing is REGISTERED as of Tuesday, June 19, 2018. This trademark is owned by NOVARTIS AG. The BEOVU trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pre...
General Information
| Serial Number | 79226907 |
| Word Mark | BEOVU |
| Filing Date | Monday, November 6, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 19, 2018 |
| Registration Number | 5494796 |
| Registration Date | Tuesday, June 19, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 3, 2018 |
Trademark Statements
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 26, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Friday, March 2, 2018 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 14, 2018 | NOTICE OF PUBLICATION |
| Tuesday, April 3, 2018 | PUBLISHED FOR OPPOSITION |
| Thursday, February 15, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, February 16, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, February 26, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 26, 2018 | ASSIGNED TO EXAMINER |
| Monday, February 26, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, November 13, 2024 | TEAS SECTION 15 RECEIVED |
| Thursday, March 21, 2024 | TEAS SECTION 71 RECEIVED |
| Tuesday, June 19, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 19, 2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Thursday, July 19, 2018 | FINAL DISPOSITION PROCESSED |
| Thursday, July 19, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, August 3, 2018 | NOTIFICATION PROCESSED BY IB |
